ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
TheraVet SA

TheraVet SA (ALVET)

0.696
-0.004
(-0.57%)
Closed May 01 11:30AM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.696
Bid
0.66
Ask
0.696
Volume
6,416
0.666 Day's Range 0.70
0.666 52 Week Range 2.55
Market Cap
Previous Close
0.70
Open
0.67
Last Trade
5
@
0.696
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
9,502
Shares Outstanding
3,223,936
Dividend Yield
-
PE Ratio
-0.97
Earnings Per Share (EPS)
-0.72
Revenue
490k
Net Profit
-2.32M

About TheraVet SA

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Charleroi, Hainaut, Bel
Founded
1970
TheraVet SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker ALVET. The last closing price for TheraVet was 0.70 €. Over the last year, TheraVet shares have traded in a share price range of 0.666 € to 2.55 €.

TheraVet currently has 3,223,936 shares outstanding. The market capitalization of TheraVet is 2.26 € million. TheraVet has a price to earnings ratio (PE ratio) of -0.97.

ALVET Latest News

TheraVet reports Full-Year 2023 Financial Results and Provides the Preparatory Documents for the General Meeting of June 6th, 2024

Significant sales growth in 2023, especially for BIOCERA-VET® OSTEOSARCOMA Portfolio strengthened with 4 new products added in 2023, for a total of 15 products Cash position of €1.15 million at...

TheraVet publie son chiffre d’affaires pour l’exercice 2023 et pour le premier trimestre 2024

Hausse de 54% des ventes d’unités de BIOCERA-VET® (toutes gammes confondues) en 2023 par rapport à l’exercice 2022 Hausse de 68% des ventes d’unités de BIOCERA-VET® OSTEOSARCOMA par rapport à...

TheraVet : BIOCERA-VET® est désormais disponible pour la prise en charge des pathologies dentaires et orthopédiques chez le cheval

Regulatory News: TheraVet (code ISIN : BE0974387194 - mnémonique : ALVET), société de biotechnologie pionnière dans le traitement des maladies ostéoarticulaires des animaux de compagnie, annonce...

BIOCERA-VET® Is Now Available for the Management of Dental and Orthopedics Conditions in Horses

Regulatory News: TheraVet (ISIN: BE0974387194 – ticker: ALVET) (Paris:ALVET), a pioneering company in the management of osteoarticular diseases in pets, announces the launch of BIOCERA-VET®...

TheraVet Retains a Leading US Veterinary Consulting Firm to Help Strategize Company Growth on the US Market

Retaining of a leading consulting firm with a solid track record of upscaling vet companies on the US market To rapidly expand TheraVet presence and be recognized as a major player in the US...

TheraVet Strengthens Its Intellectual Property With the Issuance of a Patent on VISCO-VET Technology in Europe, Israël & Singapore

Regulatory News: TheraVet (ISIN: BE0974387194 – ticker: ALVET), a pioneering company in the management of osteoarticular diseases in pets, announces that the European Patent Office (EPO), and the...

TheraVet Reports an 99% Increase in BIOCERA-VET® Units Sold in Q4 2023

BIOCERA-VET® (whole line) units sold are up 99% Year-on-Year & up 27% Quarter-over-Quarter in Q4 2023; they are up 90% Year-on-Year for H2 2023 BIOCERA-VET® OSTEOSARCOMA unit sales up 145...

TheraVet: Commercial Launch of BIOCERA-VET® in Germany

13 BIOCERA-VET® references now available in Germany, the largest companion animal health market in Europe Attendance to Leipzig Veterinary Congress, the biggest event of the country Presentation...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.084-10.76923076920.780.790.66656140.75017256DE
4-0.204-22.66666666670.90.9880.66690230.81953314DE
12-0.634-47.66917293231.331.330.66695020.96549016DE
26-0.864-55.38461538461.562.40.66672241.17308496DE
52-1.834-72.49011857712.532.550.66662621.36248066DE
156-7.104-91.07692307697.88.560.66643503.18705629DE
260-7.104-91.07692307697.88.560.66643503.18705629DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CTMXCytomX Therapeutics Inc
$ 2.80
(71.78%)
31.59M
AKANAkanda Corporation
$ 0.141
(51.61%)
108.12M
PALIPalisade Bio Inc
$ 8.925
(48.01%)
6.2M
CDNACareDx Inc
$ 9.73
(25.39%)
374.29k
SRDXSurModics Inc
$ 32.00
(24.56%)
10.87k
CETXCemtrex Inc
$ 0.2999
(-73.69%)
7.88M
CVRXCVRx Inc
$ 8.54
(-44.94%)
384.39k
XTIAXTI Aerospace Inc
$ 1.82
(-28.63%)
193.29k
GVVisionary Holdings Inc
$ 0.1921
(-24.96%)
349.3k
MNDRMobile health Network Solutions
$ 18.55
(-24.75%)
283.73k
AKANAkanda Corporation
$ 0.141
(51.61%)
108.12M
CTMXCytomX Therapeutics Inc
$ 2.80
(71.78%)
31.59M
SQQQProShares UltraPro Short QQQ
$ 12.11
(1.34%)
18.07M
TLRYTilray Brands Inc
$ 2.1848
(-11.55%)
17.77M
IMCCIM Cannabis Corporation
$ 1.025
(19.19%)
15.13M

Discussion

View Full Feed
moondogaz moondogaz 2 minutes ago
How are those line items working for you?
BEGI
Chartmaster Chartmaster 2 minutes ago
There is no dilution, here's the unrestricted OS and link for you to check daily, let us know if it changes
Unrestricted OS 6,363,667,435 04/29/2024
Share Structure: https://www.otcmarkets.com/stock/NSAV/security
NSAV
PatB1 PatB1 2 minutes ago
I'm not looking for anything to `work in my favor`. I'm pisssed that this company scammed me (us) and wants everyone to know there is no future here except for one tick flippers.
TONR
Denzel-72 Denzel-72 2 minutes ago
A new roach shows up everyday 🪳
KEGS
PennyRookie0 PennyRookie0 2 minutes ago
Don't fall in love with a stock play. Make sure you know why you are buying more.
BLFR
heisagolfer heisagolfer 2 minutes ago
where are quarterly earnings???????????????? do they not ever report?????
HOLO
snow snow 2 minutes ago
Xman My point is that SPZI did not pay anything for those assets. Those who owned shares in SPZI for instance at the beginning of December last year have not paid anything for the new assets Mr Park donated to SPZI.
SPZI
KngmAz KngmAz 2 minutes ago
Absolutely - thanks for sharing. Huge.
KSCP
Kansasjack1 Kansasjack1 2 minutes ago
May 1st is the International Workers Day or Labor Day in Vietnam! Maybe they are just buying time, and this is the way they are doing so.
FBEC
edro edro 2 minutes ago
Excuse me,it is a binding agreement.
TDRK
sweet crude sweet crude 2 minutes ago
Odds up cannabis banking bill passing

https://twitter.com/LudlowResearch/status/1785655570764107965
TLRY
Inquirig Inquirig 2 minutes ago
9. Conclusion
This dendritic vaccine trial has several limitations. These limitations include changing the primary endpoint (OS instead of PFS), creating a new study population (recurrent glioblastoma), conducting unplanned analyses, using external controls in a design originally intended to
NWBO
al44 al44 2 minutes ago
Adding it up-


https://i0.wp.com/politicallyincorrecthumor.com/wp-content/uploads/2024/05/x-gained-10-lbs-3-years-ago-8-two-inflation-left.jpg?w=520&ssl=1
Triple nickle Triple nickle 2 minutes ago
MNDR dump fest
MNDR
jbsliverer jbsliverer 3 minutes ago
Trump’s Environmental Policies Killed Thousands of People, Scientists Say
https://www.bloomberg.com/news/articles/2021-02-11/trump-s-environment-policies-killed-thousands-scientists-say


.
rbb rbb 3 minutes ago
a little progress update would go a long way...
TDRK
Sirpeter Sirpeter 3 minutes ago
I have grave concerns about this play.. shovel in hand
TONR
valuemind valuemind 3 minutes ago
Bought back more SMCI at $730
SMCI
FooBarAndGrill FooBarAndGrill 3 minutes ago
These PK trial results will be used to complete a section of the NDA.
https://investorshub.advfn.com/uimage/uploads/2024/5/1/ensuyPK-NDA.jpg
SAVA
HappyLibrarian HappyLibrarian 3 minutes ago
Until proven otherwise, I think we have to regard the 21st Century Cures Act with skepticism since, as NWBO learned the hard way, it is not what legislators intended but how regulators and insurers actually carry out a new law that matters and the past history with supposed reforms to increase patie
NWBO
BIOCHEMUP BIOCHEMUP 3 minutes ago
RSI is back at 58. The climb up should be thin. We lost some stupid shareholders due to the yield. If I had more cash I would be buying here.
BLEG
Invest83838 Invest83838 3 minutes ago
I'm looking forward to future selling opportunities

since we have had enough buying opportunities to last a lifetime
AMRN
koolmc koolmc 3 minutes ago
nsav grabbed some again on dip for bounce trade overreaction
ap17 ap17 3 minutes ago
From Nutshell, "Perspective:
SOME PERSPECTIVE 🏦
Bitcoin & the wider crypto market has been ugly over the last month.

Many are pointing the blame at the Bitcoin ETFs, which after a rocket ship-like start, have begun having zero flow days.

Are the ET
BTCUSD
Jaxon2010 Jaxon2010 3 minutes ago
Lmao

Coming down to 500! Come on bitch!!

Not worried about IGPK!
IGPK

Your Recent History

Delayed Upgrade Clock